ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

Evert S.M. van Aken, Ajeet Kumar Gandhi, Sean M. O’Cathail, Gerben Borst, Jorge Barriuso, Emmanouil Fokas, Luis Castelo-Branco, Anne Hansen Ree, Evandro de Azambuja, Stephanie Kroeze, Ilaria Colombo, Antonin Levy, Carmen Criscitiello, Maximilian Niyazi, Nadia Harbeck, Ewa Szutowicz, Gabor Liposits, Marcel Verheij, Isabelle Ray-Coquard, Paolo Tarantino, Dario Trapani, Paulien Boot, Claus Belka, Dirk De Ruysscher, George Pentheroudakis, Corrie A.M. Marijnen, Florian Lordick, Umberto Ricardi, Diogo Martins-Branco, Arsela Prelaj, Monique C. de Jong, Bharti Devnani

Open source

DOI: 10.1016/j.radonc.2025.111330
Published: 2026-02
Container: Radiotherapy and Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2025.111330,
  title = {ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors},
  author = {Evert S.M. van Aken and Ajeet Kumar Gandhi and Sean M. O’Cathail and Gerben Borst and Jorge Barriuso and Emmanouil Fokas and Luis Castelo-Branco and Anne Hansen Ree and Evandro de Azambuja and Stephanie Kroeze and Ilaria Colombo and Antonin Levy and Carmen Criscitiello and Maximilian Niyazi and Nadia Harbeck and Ewa Szutowicz and Gabor Liposits and Marcel Verheij and Isabelle Ray-Coquard and Paolo Tarantino and Dario Trapani and Paulien Boot and Claus Belka and Dirk De Ruysscher and George Pentheroudakis and Corrie A.M. Marijnen and Florian Lordick and Umberto Ricardi and Diogo Martins-Branco and Arsela Prelaj and Monique C. de Jong and Bharti Devnani},
  year = {2026},
  journal = {Radiotherapy and Oncology},
  doi = {10.1016/j.radonc.2025.111330},
  url = {https://doi.org/10.1016/j.radonc.2025.111330}
}

RIS

TY  - JOUR
TI  - ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors
AU  - Evert S.M. van Aken
AU  - Ajeet Kumar Gandhi
AU  - Sean M. O’Cathail
AU  - Gerben Borst
AU  - Jorge Barriuso
AU  - Emmanouil Fokas
AU  - Luis Castelo-Branco
AU  - Anne Hansen Ree
AU  - Evandro de Azambuja
AU  - Stephanie Kroeze
AU  - Ilaria Colombo
AU  - Antonin Levy
AU  - Carmen Criscitiello
AU  - Maximilian Niyazi
AU  - Nadia Harbeck
AU  - Ewa Szutowicz
AU  - Gabor Liposits
AU  - Marcel Verheij
AU  - Isabelle Ray-Coquard
AU  - Paolo Tarantino
AU  - Dario Trapani
AU  - Paulien Boot
AU  - Claus Belka
AU  - Dirk De Ruysscher
AU  - George Pentheroudakis
AU  - Corrie A.M. Marijnen
AU  - Florian Lordick
AU  - Umberto Ricardi
AU  - Diogo Martins-Branco
AU  - Arsela Prelaj
AU  - Monique C. de Jong
AU  - Bharti Devnani
PY  - 2026
JO  - Radiotherapy and Oncology
DO  - 10.1016/j.radonc.2025.111330
UR  - https://doi.org/10.1016/j.radonc.2025.111330
ER  -

APA

Aken, E. S. V., Gandhi, A. K., O’Cathail, S. M., Borst, G., Barriuso, J., Fokas, E., Castelo-Branco, L., Ree, A. H., Azambuja, E. D., Kroeze, S., Colombo, I., Levy, A., Criscitiello, C., Niyazi, M., Harbeck, N., Szutowicz, E., Liposits, G., Verheij, M., Ray-Coquard, I., Tarantino, P., Trapani, D., Boot, P., Belka, C., Ruysscher, D. D., Pentheroudakis, G., Marijnen, C. A., Lordick, F., Ricardi, U., Martins-Branco, D., Prelaj, A., Jong, M. C. D., & Devnani, B. (2026). ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2025.111330

Source records

crossref · retrieved 2026-09-25T10:10:14.541Z